Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients.
Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe
dosage is identified that can be used in diffuse diabetic macular edema for treatment. in
this study, we are going to compare the effect of intra vitreal injection of Diclofenac and
Bevacizumab in primary treatment of diffuse diabetic macular edema.